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Receptors for the Fc domain ofIgG (FcR) are present on a variety of cell types
and mediate interactions between the intracellular and humoral compartments .
Of the three FcR types identified on human leukocytes, the low-affinity FcR for
immune complexed IgG (CD16) is present on NK cells and neutrophils (l, 2)
and is biochemically similar to the low-affinity FcRII for murine IgGl/IgG2b
detected on murine macrophages and B cells by antibody 2.4G2 (3), which also
detects an Fc on murine NK cells (Perussia, B., Tutt, M., Trinchieri,G., Kumar,
V., manuscript in preparation) . CD16 on human NK cells and neutrophils are,
like the FcR on murine B cells and macrophages, antigenically crossreactive (1,
4) . These observations suggest the possibility that CD 16 is the human equivalent
of FcR11 . Two genes have been identified that encode murine FcR11: one
expressed in macrophages, and one in both macrophages and lymphocytes (5);
cloning ofhuman FcR gene(s) has not been reported yet . The sequences obtained
for these FcRII genes indicate that they belong to the Ig supergene family (5).
The extracellular domains of their products are 95% homologous, independent
of the cell type on which they are expressed, but transmembrane and cytoplasmic
domains in the different cell types bear no homology . Most proteins encoded by
members of the Ig supergene family are surface molecules or receptors involved
in recognition of membrane-associated or soluble moleculesand transduce signals
intracellularly upon ligand binding .
Unlike monocytes and neutrophils (6, 7), human NK cells bear only one type
of FcR (i.e ., CD16), which represents, at present, the only defined receptor
expressed on NK cells and not on other lymphocyte subsets . It is through this
surface molecule that the activity ofNK cells can be specifically targeted toward
cells sensitized with IgG antibodies . We showed that interaction of the NK cell
FcR with immune complexes, with anti-CD16 antibodies, or with IgG antibody-
sensitized target cells, all induce similar down-modulation of FcR (CD16) (4, 8)
and trigger cellular events that result in exhaustion of cytolytic potential of the
cells (9) . Enhancement ofNK cell activity upon interaction of the cells with anti-
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CD16 antibodies has also been reported (10). The effects observed in NK cells
upon FcR ligand binding are reminiscent of those observed in CD3' T cells upon
interaction of antigens with TCR or of antibodies with the TCR-associated
molecule CD3. CD3 antigen modulation is induced in these conditions (11) and
T cells undergo a series of metabolic events that include both activation (12-14)
and inactivation or refractoriness to further stimulation (15, 16). In the case of
T cells, two distinct stimuli are necessary to induce maximal activation (17).
NK cells bear the gp75 molecule that binds IL-2 with low affinity (18) and,
upon stimulation with high doses of IL-2, are activated to secrete lymphokines
(e.g., IFN-y) (19), to express activation antigens, e.g., Tac(CD25), and eventually
to undergo proliferation (20, 21). Upon recognition and binding of target cells
through a putative NK cell receptor, NK cells release cytotoxic molecules (22)
and our data indicating that TNF is released in the supernatant from NK target
cell cocultures (23) suggest the possibility that NK cells produce this cytokine
upon specific stimulation .
Detailed studies of the intracellular events after NK cell stimulation with
specific (immune complexes, target cells) or nonspecific (IL-2) ligands have been
hampered by the difficulty of obtaining sufficient numbers of cells either from
fresh peripheral blood or from clonally expanded cultures. We developed an in
vitro short-term bulk culture system that allows us to obtain large numbers of
homogeneous NK cell preparations with all characteristics of fresh NK cells but
activatable with faster kinetics (24, 25). Here, we used these cells to study the
role of FcR(CD16) in NK cell activation and the mechanisms on which such
activation depends.
Materials and Methods
Cell Lines.
￿
The human B lymphoblastoid cell lines RPMI 8866 and Daudi, and the
murine mAb-producing hybrid cell clones were maintained in culture in RPMI 1640
(FlowLaboratories, Inc., Rockville, MD) supplemented with 10% FCS (FlowLaboratories,
Inc.). All cell lines were free of mycoplasma contamination on repetitive testing.
Monoclonal and Polyclonal Antibodies. mAbs B73.1 (IgGI, anti-CD16) (26), B36.1
(IgG2b, anti-CD5) (27), B33 .1 (IgG2a anti-HLA-DR nonpolymorphic determinant (8),
B52.1 (IgM, anti-CD14 on monocytes), and B13.4 (IgM,anti-monocyte/granulocytes) (27,
28) were produced and characterized in our laboratory. 3G8 (IgGI, anti-CD16) (2) was
produced from cells kindly provided by Dr. J. Unkeless (Mount Sinai Medical School,
New York, NY); N901 (IgGI, anti-NKH-1 antigen) (29) and Tac (IgGI, anti-IL-2R,
CD25) (30) were kindly provided by Drs. J. Griffin (Dana Farber Cancer Institute, Boston,
MA) and T. Waldmann (National Institutesof Health, Bethesda, MD), respectively. OKT3
(IgG2a, anti-CD3), 5E9 (IgGI, anti-transferrin receptor (Tf-R), 4F2 (IgGI, anti-lympho-
cyte activation antigen), and W6.32 (IgG2a, anti-HLA class I nonpolymorphic determi-
nant) were produced from cells obtained from the American Tissue Culture Collection
(Rockville, MD). The anti-IFN-y B133 .1 and B133.5 and the anti-TNF B154.7 and
B154.9 used for the IFN-y and TNF RIA were produced and characterized in our
laboratory (19, 31). FITC-labeled antibodies Leu-19 (IgGI, anti-NKH-1) and Leu-1
(IgG2b, anti-CD5) (32) were kindly provided by Dr. L. Lanier and N . Warner (Becton
Dickinson & Co., Mountain View, CA). When indicated, purified antibodies were labeled
with biotin or linked to CNBr-Sepharose 4B (Pharmacia Fine Chemicals, Uppsala, Sweden)
according to routine procedures. The polyclonal FITC-goat F(ab')i anti-mouse Ig and
the rabbit IgG antibodne erythrocytes (E) were purchased from Cappel Laboratories
(Cochranville, PA). The goat F(ab')1 anti-mouse IgG used to prepare the E for indirect454
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rosetting was produced in our laboratory, absorbed on human IgG, and affinity purified
on mouse IgG-Sepharose 4B column (Pharmacia Fine Chemicals).
Peripheral Blood Lymphocytes, NK, and T Cells.
￿
Venous peripheral blood was obtained
by venipuncture from adult healthy donors and anticoagulated with heparin . PBMC were
separated on Ficoll-Hypaque density gradient (Lymphoprep; Nyegaard and Co., Oslo,
Norway). PBL were obtained from PBMC depleted of monocytes after two cycles of
adherence on plastic surfaces (45 min, 37°C) and depletion of B52.1/B13 .4+ cells by
indirect antiglobulin rosetting (26). To obtain large numbers of NK cells, short-term bulk
cultures of these cells were prepared as previously described in detail (24, 25). Briefly,
PBMC were cultured at 37°C with 50 Gy-irradiated RPM1 8866 or Daudi B lympho-
blastoid cells for 10 d (5:1 PBMC/B lymphoblastoid cells, 2 .5 x 105 PBMC/ml RPMI-
10% FCS) in tissue culture plates in a 5% COz humidified atmosphere. The total number
of cells recovered after a 10-d culture is increased, on average, 10-fold, and the cell
population is ^-60-80% CD16+/NKH-1 +/CD3- NK and 20-40% CD3+/CD16-/NKH-1 -
T cells. Homogeneous populations of NK and T cells were negatively selected and purified
by density gradient centrifugation after sensitization of the lymphocytes with a mixture
of antimonocyte B52.1 and either anti-CD3 and anti-CD5, or anti-CD16 and anti-NKH-
1 antibodies, respectively, and indirect rosetting with CrCI3-treated goat anti-mouse Ig-
coated E (26). Both the NK and the T cells purified from these cultures have morphologic,
phenotypic, genotypic, and functional properties identical to those of the two subsets
freshly obtained from PBL (24, 25). Unlike fresh cells, however, the majority of these
cells express HLA-DR antigens. A small proportion (5-10%) of the NK cells bear
Tac(CD25) at low density and the cells can be induced to proliferate with fast kinetics in
response to rIL-2 without added accessory cells. Similarly, T cells respond with fast
kinetics to rIL-2, and a proportion of them bear Tac at higher density than the NK cells
purified from the same cultures. Monocytes and B cells were not detected in the cultures
on day 10 (25).
Lymphocyte Stimulation.
￿
The purified fresh PBL, the NK and T cell subpopulations
obtained from the bulk cultures were cultured (37°C, 5 x 106 cells/ml RPMI-10% FCS)
for the indicated periods of time with different inducers. FcR(CD16) ligands were: (a)
anti-CD16 antibodies (3G8 or B73 .1) used in either soluble form (1 wg IgGI/ml) or linked
to CNBr-Sepharose 4B (5 mg antibody/ml Sepharose, 10,ul beads/ 10' cells), (b) particulate
immune complexes, i.e., IgG-sensitized bovine E (EA7S) prepared as previously described
(4). Sepharose-linked irrelevant antibodies (anti-CD3 OKT3, anti-HLA class I W6.32) and
E were used as controls. When indicated, purified human rIL-2 was present (100 U/ml)
(rIL-2, 5 x 106 U/mg in a standard CTLL assay; Takeda Chemical Industry, Inc., Osaka;
kindly provided by Dr. T. Taguchi, Osaka University, Osaka, Japan). In some cases the
stimuli were added to cells pretreated with cycloheximide (10 ug/ml, 1 h at 37°C)
(Calbiochem-Behring Corp., La Jolla, CA); cycloheximide was present throughout the
culture period. After culture, the cells were collected, Sepharose beads were detached by
vigorous vortexing, and eliminated from the cell suspension after a 1-min centrifugation
at 500 rpm. Particulate immune complexes were removed by lysis with hypotonic medium.
Ligand-free cells were washed and used for the different assays. Cell viability was >95%
in all conditions and recovery was ^-80% of the original input without loss of lymphocyte
subsets.
IFN-y and TNF RIA.
￿
These were performed as previously described in detail (31, 33)
on cell-free supernatants obtained from the cells induced as above. Purified human natural
IFN-y (Interferon Sciences, New Brunswick, NJ) and purified human rTNF (5 x 10'
U/mg on L929 cells, kindly provided by Dr. H. M. Shepard, Genentech Inc., South San
Francisco, CA) were used in each assay to construct the standard curve. Sensitivity of the
RIA for IFN-y was 0.2 U/ml, of that for TNF, 0.1-0.2 U/ml.
Immunofluorescence.
￿
Indirect and direct immunofluorescence were performed as pre-
viously described in detail using an FITC-goat F(ab')2 anti-mouse Ig (Cappel Laborato-
ries) preabsorbed on human IgG (26), or predetermined saturating concentrations ofANEGON ET AL.
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biotin-labeled antibodies detected with phycoerythrin (PE)'-labeled avidin (Becton Dick-
inson & Co.) and FITC-labeled antibodies (4), respectively. Irrelevant antibodies of
matched isotypes were used as negative controls. The sampleswere analyzed on an Ortho
Cytofluorograf 50H connected to a 2150 Data Handling System (Ortho Diagnostic
Systems Inc., Westwood, MA). Intensity of fluorescence was measured on a logarithmic
scale.
Northern and Dot Blot Hybridization.
￿
Northern blots were performed as previously
described in detail (31). Briefly, total cytoplasmic RNAs were extracted from uninduced
and induced cells. Equalamountsof RNA(20 /Ag/lane, as quantified by spectrophotometric
reading at 260 and 280 nm) were size fractionated in a 1% agarose-formaldehyde gel.
Ethidium bromide-stained gels were visualized to assess integrity of RNA and to verify
the loaded amounts. RNA were transferred by capillarity to nitrocellulose paper and
hybridized with nick-translated purified cDNA fragments bearing human IL-2-R, IFN-'y,
or TNF sequences. When dot blots were used, sequential 1:3 dilutions of RNA (starting
from 2 leg) were applied to nitrocellulose using a dot blot apparatus (Schleicher and
Schuell, Keene, NH). After hybridization and washing, the filters were autoradiographed
using XAR film (Eastman Kodak, Rochester, NY) and an intensifying screen (Dupont
Co., Wilmington, DE). The cDNA probes used were: IL-2R2 for IL-2-R, kindly provided
by Dr. W. Green (NIH, Bethesda, MD), TNF" provided by Dr. H. M. Shepard (Genentech
Co.), and pSWIF for IFN-y provided by Dr. S. Clark (Genetics Institute, Boston, MA).
Human (3-actin probe, pBR322, pBAE probe for 28S ribosomal RNA, and pSP64 were
used as controls and were kindly provided by Dr. R. Weinmann and P. Curtis (Wistar
Institute).
Nuclear Transcription Analysis (Run-On Assays).
￿
Nuclei from 20 min-stimulated and
unstimulated cells were isolated as described by Kronke et al. (34). Briefly, cells were
lysed in 10 mM Tris buffer (pH 7.5) containing 2 MM MgCl2, 3 mM CaCl2, 3 mM DTT,
300 mM sucrose, and 0.3% NP-40. Nuclei were pelleted by centrifugation over a 750-
mM sucrose gradient. In vitro transcription was according to Groudine et al. (35) with
slight modifications. Nuclei were resuspended in a solution containing 1 MM M9Cl2, 70
mM KCI, glycerol 15%, 2.5 mM DTT, 0.25 mM each ATP, GTP, and CTP (Sigma
Chemical Co., St. Louis, MO), and 400 ACi [s2p]UTP (sp act ^400 Ci/mM; Amersham
International, Amersham, United Kingdom). After a 25-min incubation at 26 °C, the
reaction was stopped adding sequentially RNase-free DNase I (Promega, Madison, WI)
and Proteinase K (Calbiochem-Behring Corp., San Diego, CA). Nuclear RNA (nRNA)
was isolated as described by Gariglio et al. (36) by extraction with phenol/chloroform and
chloroform, and isopropyl-alcohol precipitation at -70°C. The pellet was resuspended in
10 mM Tris (pH 8.0) 1 mM EDTA and free "P was eliminated on a Sephadex G-50 spin
column (Boehringer-Mannheim Biochemicals, Indianapolis, IN). After repeating the DNA
and protein digestion and RNA extraction and precipitation, the samples were washed in
ethanol 80%, dried, and resuspended in hybridization solution (20mM sodium phosphate
buffer, pH 6.5, 50% formamide, 5X SSC [IX: 0.15 M NaCl, 0.015 M sodium citrate pH
7.0], IX Denhardt's solution [0.02% polyvinylpyrrolidone, 0.02% BSA, 0.02% Ficoll
400], 100 teg/ml denaturated salmon sperm DNA, 0.1 % SDS). Incorporated radioactivity
was determined by liquid scintillation counting and equal amounts of radioactivity per
sample were heat denaturated and resuspended (5-7.5 X 106 cpm/ml) in hybridization
solution. The same number of 12P-labeled nRNA cpm per sample were hybridized (3 d)
at 42 °C with prehybridized nitrocellulose filters on which 10 ug of linearized plasmid
cDNAs had been immobilized using a slot-blot apparatus (Schleicher & Schuell, Inc.,
Keene, NH). Filters were washed twice with 2X SSC and 0.1% SDS at 37°C and, after
rinsing with 2X SSC, were incubated (30 min, at 37°C) in 2X SSC with 10 Ag/ml RNase.
After two washes in 0.1 X SSC and 0.1 % SDS at 65 °C for 30 min, filters were dried and
exposed to Kodak XAR film with intensifying screens. Extent of hybridization was
quantitated by scanning densitometry with an LKB laser densitometry (Ultrascan XL;
LKB Instruments, Inc., Gaithersburg, MD) on films exposed for the appropriate length
' Abbreviations used in this paper:
￿
EA7S, IgG antibody-sensitized E; LGL, large granular lympho-
cyte; PE, phycoerythrin; Tf, transferrin.456
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of time to produce bands with absorption within the linear response range. To calculate
the rate of transcription, background hybridization to pBR322 or pSP64, whichever
applicable, was sutracted from the densitometric values and these were normalized relative
to values obtained for the 28S rRNA probe pBAE.
Results
FcR(CDI6) Crosslinking at the NK Cell Membrane Induces Expression of Tac
(CD25) Antigen in Fresh Peripheral Blood NK Cells. Total PBL populations were
cultured with insolubilized CD 16 ligands and the proportion of T and NK cells
induced to express Tac antigen was analyzed in two-color immunofluorescence.
5.4% of resting PBL (average of results from four experiments performed,
representative results with PBL from one donor are reported in Fig. 1) express
Tac antigen at minimal density (Fig. 1, top panels), and this proportion is
unchanged upon an 18-h incubation with rIL-2 (not shown). After 18 h of culture
in the presence of particulate immune complexes (EA7S, not shown) or Sepha-
rose-linked B73 .1 antibody (Fig. 1, panels in third row) an average of 9.8% of
PBL were Tac+. Tac was expressed on an average of 23.9% of the NKH-1(Leu-
19+) NK cells, but only on 4.3% of the CD5(Leu-l+) T cells (or CD3 (OKT3+)
cells, not shown). The proportion of Tac+ PBL increased, on average, to 14.7%
and 23% when PBL were stimulated with EA7S (Fig. 1, panels in second row)
or with Sepharose-linked anti-CD16 antibody B73 .1 (Fig. 1, bottom panels),
respectively, in the presence of rIL-2 (100 U/ml). In these cases, Tac was
expressed on 31 .3% and 40.8% of the NKH-1+ cells, and on 8 .2% and 11 .8% of
the CD5+ T cells, respectively. The proportion of NKH-1+ or CD5+ cells
(average, 16.5% and 68.0%, respectively) and that of HLA-DR' cells were
unchanged under any of the experimental conditions. No Tac antigen expression
was induced on PBL upon culture with soluble anti-CD16 antibodies, Sepharose-
linked anti-HLA class I antibodies, or nonsensitized E, independently of the
presence of rIL-2 (data not shown).
Interaction of FcR(CDI6) Ligands with Cultured NK Cells Induces Expression of
Surface Activation Antigens. Negatively selected CD3/CD5- NK cells were ob-
tained from the 10-d coculture of PBMC with irradiated B lymphoblastoid cells.
The proportion of cells expressing different surface antigens was detected by
indirect immunofluorescence (Table I and Fig. 2). The majority of the
CD3/CD5-, CD16/NKH-1' cells were HLA-DR', an average of 12% of them
expressed Tac antigen or TfR at low density, and ^-3% of the cells expressed
4F2 antigen (Table I). No significant antigenic change was detected upon culture
of the cells (18 h, 37°C) in the presence of rIL-2. Soluble anti-CD16 antibodies
(not shown), Sepharose-linked anti-CD3 or anti-HLA class I antibodies, or E
either in the presence or absence of rIL-2 (Table I) did not affect the expression
of Tac, TfR, and 4F2. As we previously demonstrated using fresh PBL (4, 8),
interaction of NK cells with FcR ligands induced down-modulation of the CD16
antigen, and this effect was not reversed in the presence of rIL-2 . When NK
cells were incubated with Sepharose-linked anti-CD16 antibody B73 .1 the pro-
portion of Tac+ cells increased, on average, to 27% and, when rIL-2 was present
during the incubation, to 54% (Table I). In the presence of rIL-2 the density of
Tac antigen on the positive cells, as evaluated from fluorescence intensity, was
much higher than in cells treated with Sepharose-linked anti-CD16 antibodiesANEGON ET AL .
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FIGURE 1 .
￿
Induction of expression of Tac antigen in fresh PBL stimulated with FcR(CD16)
ligands. PBL from one donor were incubated (18 h, 37 ° C) in the presence of the indicated
stimuli. Surface antigen expression was evaluatedby two-color immunofluorescence . Tac was
detected using biotin-labeled anti-Tac and PE-avidin (red fluorescence ; second, third, and
fourth columns of contour plots), NKH-1 and CD5 were detected using the FITC-labeled
antibodies indicated on the top of the columns (green fluorescence) . Correlate measurements
of green (x-axis, log scale) and red (y-axis, log scale) fluorescence are displayed as two-
dimensional contour plots . Basedon the negative control samples in the absence of antibodies
(contour plots in the first column), the contour plots were divided into quadrants, indicating :
(a) cells with red fluorescence (binding PE-avidin only) ; (b) double-positive cells ; (c) double-
negative cells ; (d) cells with green fluorescence (binding FITC-labeledantibody only) . Numbers
in the top right corner of each scattergram indicate the proportion of cells in the respective
quadrants . The numberson the scales refer to arbitrary units of fluorescence intensity .
only (Fig . 2) . The proportion ofTfR+and of 4F2' cells increased similarly under
the same conditions, whereas no significant changes were detected in the expres-
sion of HLA-DR antigens under any condition . Analogously to the stimulation
with anti-CD16 antibodies, stimulation of NK cells with particulate (EA7S)
immune complexes induced increased expression of Tac antigen (Table I) and
TfR and 4F2 antigens (not shown), and the presence of rIL-2 potentiated this
effect . In all these experimental conditions, the proportion of NK cells, as
detected by expression of NKH-1 antigen, was unchanged and that of CD3+ (or
CD5+ , not shown) cells remained <2%.
CD16- T cells were also purified from the 10-d PBMC cultures and analyzed
under conditions identical to those used for NK cells (Fig . 2, bottom panel,45 8
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TABLE I
FcR(CD16) Ligands Induce Expression ofActivation Antigens on NK Cells
* (.D3/CD5(-) NK cells purified from 10-d cultured PBMC were incubated (18 h, 37°C) in the presence of the indicated inducers.
$ In the top part ofthe table, n = 6, in the bottom part, n = 4.
4Surface antigens were detectedby indirect immunofluorescence, using theindicated mAbs: The values of background fluorescence in control
samples treated with isotype-matched irrelevant antibody and FITC-goat anti-mouse Ig (I-2% in the different conditions) have been
subtracted.
I
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FIGURE 2.
￿
Interaction of anti-CDI6 antibody with cultured NK cells induces expression of
Tac(CD25) antigen, CD3/CD5- NK cells and CD16/NKH-1 - T cells purified from 10-d
cultures of PBMC were incubated (18 h, 37'C)with the indicatedSepharose-linked antibodies
with or without rIL-2 (100 U/ml). CD25 antigen expression was detected in indirect immu-
nofluorescence with anti-Tac (solid line in each histogram). The broken line is the histogram
of the fluorescence of cells treated with FITC-labeled second antibody only. x-axis, intensity
of fluorescence (exponential scale); y-axis, number of cells.
representative of eight experiments). Tac antigen expression (both proportion
of positive cells and intensity of fluorescence) was higher on the purified T cells
than on the NK cells. Enhanced expression of Tac antigen was induced on T
cells stimulated with Sepharose-linked anti-CD3 antibody in the presence of rIL-
2, but not with HL-2 alone or with Sepharose-linked anti-CD16 or anti-HLA
class I antibodies in the presence or absence of HL-2 .
FcR(('D16) Ligands Induce Production of Cytokines by NK Cells: Synergy with rIL-
2. NK cells obtained from the 10-d cultures of PBMC with irradiated B
lymphoblastoid cells do not spontaneously produce significant levels of either
Medium rIL-2 =Sepharose-073 .1
Sepharose-073.1
+ HL-2
Sepharose-W6.32
+ rIL-2
Sepharoee-OKT3
+ rIL-2
NK Cells
CD5
CD3
())]
"
III AMM0 _ O - _
T cells
[CD16(-),
NKH1 (-)]
n
I 1
I W'N'
Percent expressing (mean ± SD, n experiments)# surface antigensf (mAbs):
Induce,* CD16
(3G8)
NKH-1
(N901)
CD3
(OKT3)
CD25
(Tac)
Tf-R
(5E9) 4F2
HLA-DR
(033.1)
None 90.9±3.0 86.6±7.6 1 .9±0.1 12.3±6.3 10.8±7.0 3.3±0.5 82.8±4.8
rl1.-2 (1000/nil) 86.0±5.6 86.4±5.0 1 .1±1.1 7.1±1.1 7.5±3.0 4.4±0.4 78.2±3.7
Sepharose-873.1 14.9 ± 3.0 75.2 ± 7.0 0.5 ± 0.7 27.3 ± 7.4 23.4 ± 11.3 15.6 ± 7.5 82.6 ± 3.6
Sepharose-873.1 + rIL-2 111.2 ± 3.4 78.0 ± 9.8 2.0 ± 1.0 53.9 ± 12.0 42.4 ± 12.5 38.2 ± 17.7 88.2 ± 1 .3
Sepharose-W6 .32 + rll..--2 92.3 ± 4.7 90.5 ± 3.0 4.9 ± 4.1 10.7 ± 2.8 10.8 ± 2.0 8.1 ± 2.5 86.7 ± 3.0
Sepharose-OKT3 + rll.-2 89.0 ± 8.0 92.0 ± 2.0 2.4 ± 1.8 10.3 ± 1 .0 10.5 ± 3.3 5.7 ± 3.8 90.0 ± 4.0
CD]6
(3G8)
NKH-I
(N901)
CD3
(OKT3)
CD25
(Tac)
None 81.7±7.7 85.2±6.0 2.5±0.3 9.2±6.7
r1t,2(100U/ml) 88.2±1 .2 90.0±4.0 1 .5±1.5 3.8±2.2
E 73.0±10.5 74.7±1.2 2.1±1.6 11 .5±8.5
E+rl1-2 89.1±5.3 90.6±5.0 1 .6±1.5 4.2±3.4
EA7S 11.2±7.0 67.2±8.8 1 .8±1.8 13.8±5.0
EA7S+111:2 5.0±5.0 71.6±8.1 2.2±5.0 40.5±14.0ANEGON ET AL.
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TABLE II
FcR(CD16) LigandsInduce NK Cells to ProduceLymlbhokines
* CD3/CD5(-) NK cells purified from 10-d cultures of PBMC were
incubated (18 h, 37°C) with the indicated inducers, without(-)or with
(+) rIL-2 added. IFN-y and TNF in the cell-free supernatants were
tested by RIA.
Mean ±SE.n=9.
IFN-y or TNF (Table II) and respond to HL-2 stimulation with production of
low levels ofIFN-y (^-10 U/ml), but not TNF. Culture ofthe cells in the presence
ofCD16 ligands(either Sepharose-linked anti-CD16 antibodies or EA7S) resulted
in production of low levels of both IFN-y (-40 U/ml) and TNF (^-8 U/ml).
When both rIL-2 and FcR ligands were present during the 18-h culture, levels
ofIFN-y and TNF significantly higher than the sum ofthose induced by the two
stimuli separately were reproducibly detected (on average 300 U/ml and 50
U/ml, respectively). As reported in Table II and Fig. 3 (A and B), neither
Sepharose-linked irrelevant antibodies (anti-CD3 OKT3 and anti-HLA class I
W6.32) nor E, in the presence or absence ofHL-2, induced cytokine production.
T cells obtained from the same cultures were induced to produce both IFN-y
(on average 150 U/ml) and TNF (on average 100 U/ml) when stimulated with
Sepharose-linked anti-CD3 antibodies and HL-2 (Fig. 3, C and D; experiment
reported in Fig. 3 representative of six performed), but not under conditions
that induced cytokine production from NK cells.
Kinetics ofInduction of Tac(CD25) Antigen Expression and Cytokine Production by
NK Cells Stimulated with FcR(CD16)Ligands. Sepharose-linked anti-CD16 (3G8)
antibody or immune complexes (EA7S) both in the presence or absence of rIL-
2 (Fig. 4A) induced Tac antigen expression in a proportion of NK cells higher
than that present in untreated NK cells starting at 7-h incubation . As shown in
Fig. 2, however, at any time point the density oftheantigen on the cells incubated
with both stimuli was significantly higher than that observed using the CD16
ligands alone. The proportion ofTac+ cells (and density of antigen expression,
not shown) increased to 50-60% at 18 h and remained constant up to 24 h of
culture. IFN7 (Fig. 4, panel B) and TNF (Fig. 4, panel C) were not produced at
Inducer*
rIL-2
(100
U/ml)
Lymphokine:~
IFN-y TNF
U/ml
None - 0.2±0.1 1.1 ±0.4
+ 10.6 ± 3.4 1.7 ± 0.6
Sepharose-1373.1 - 43.3 ± 17.1 8.0 ± 3.5
+ 313.0±124.1 56.5±26.2
Sepharose-OKT3 - 3.8 ± 2.1 4.0 ± 1.2
+ 3.4 ± 0.8 0.7 ± 0.3
Sepharose-W6.32 - 2.3 ± 2.2 2.0 ± 1.9
+ 0.6±0.6 0.3±0.2
E - 7.2±7 .2 1.0±0.3
+ 14.7 ± 4.9 1.3 ± 0.6
EA7S - 8.4±4 .0 7.7±2.7
+ 271.5 ± 88.5 22 .6 ± 10.8
PDBu/A23187 - 525.0 ± 110.8 68.9 ± 29.4460
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FIGURE 3 . Interaction of NK cells with
FcR(CD16) ligands induces lymphokine produc-
tion . CD3/CD5- NK cells (A and B) and
CD16/NKH-1- T cells (C and D) were purified
and stimulated as in Fig . 2 . Cell-free supernatants
were collected after 18 h of culture at 37°C and
tested for the presence ofTNF (A and C) andIFN-
y (B and D) by RIA .
FIGURE 4. Kinetics of induction of Tac-
(CD25) antigen expression and lymphokine
production by NK cells stimulated with
FcR(CD16) ligands . CD3/CD5- NK cells were
purified and stimulated as in Fig . 2 . Cells were
collected at the indicated time points and tested
for Tac expression by direct immunofluores-
cence (A); IFN-y (B) and TNF (C) in the cell-
free supernatants were tested by RIA . The
stimuli used were : (0) none, cells cultured in
medium only ; (0) rIL-2, 100 U/ml ; (A) Sepha-
rose-linked3G8antibody ; (A) Sepharose-linked
3G8and rIL-2, 100 U/ml ; (p) EA7S ; (/) EA7S
and rIL-2, 100 U/ml . Proportion of Tac' cells
before culture was 9.8% and after culture, in
medium or rIL-2, 10.4%. Cell-free superna-
tantsfrom cells cultured 18 h in medium con-
tained 0.4 U/ml IFN-y and 0.8 U/ml TNF,
those from cells cultured with rIL-2 contained
5.4 and 1 .0 U/ml, respectively.
significant levels in supernatants of NK cells stimulated with HL-2 alone or with
either type of FcR(CD16) ligands in the absence of HL-2 . When FcR(CD16)
ligands and HL-2 were simultaneously present during the culture, significant
levels of both IFNy (50 U/ml in the experiment in Fig. 4, representative of 4
0
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FIGURE 5 .
￿
Accumulation of IL-2-R (A), IFN--y (B), andTNF (C) mRNA in human NK cells
stimulated with FcR(CD16) ligands . Total cytoplasmic RNA, extracted from NK cells
(CD3/CD5- cells from 10-d cultures ofPBMC with irradiated RPMI 8866 cellsandincubated
[2.5 h, 37°Cl in the presence of various inducers) were electrophoresed on 1% agarose-
formaldehyde gel (20,ugmRNAper lane) . After transfer to nitrocellulose,RNAwas hybridized
to the indicated cDNA probes. Amount and integrity of RNA was checked by ethidium
bromide staining (D). Cellswere cultured in the presence of. (Lane 1) medium ; (lane 2) HL-2
(100 U/ml) ; (lane 3) Sepharose-873.1 antibody; (lane 4) Sepharose-873.1 and rIL-2 ; (lane 5)
Sepharose-W6.32; (lane 6) Sepharose-W6.32and HL-2 .
performed) and TNF (15 U/ml) were detected at 7-h incubation, and these levels
increased further at 18-h incubation .
FcR(CD16) Antigen Crosslinking at the NK Cell Surface Induces Accumulation of
mRNA for Cytokines and IL-2-R. Northern blot analysis was performed on
cytoplasmic RNA obtained from NK cells purified from 10-d cultures and
stimulated for 2.5 h with Sepharose-linked anti-CD 16 antibody B73.1 with or
without rIL-2 added . The degree of mRNA accumulation induced under the
different conditions was quantitated spectrophotometrically . As shown in Fig . 5,
IL-2-R (A), IFN-y (B), and TNF mRNA (C) were barely detectable in NK cells
immediately after purification . Stimulation with rIL-2, and, to a lesser extent,
with CD16 ligands, induced accumulation of themRNA for IL-2-R . The values
obtained for IL-2-R mRNA levels induced by CD16 ligand and rIL-2 together
were higher (as determined by densitometric scanning of the autoradiograms)
than the sum of those obtained using either stimulus alone in two of eight
experiments performed and equal to the sum in the other six . rIL-2 and, to a
higher degree in most experiments, CD16 ligands alone induced accumulation
of both IFN-y and TNF cytoplasmic mRNA . mRNA accumulations with the
combined stimuli were always higher than 2-fold the sum of those obtained with
either stimulus along in the case of IFN-y (average 4-fold in eight experiments),
and in five of seven experiments in the case of TNF (average 3.5-fold in five
experiments) . Identical results were obtained using particulate immune com-
plexes (EA7S) in place of the Sepharose-linked anti-CD16 antibody (not shown) .
Sepharose-linked anti-HLA class I antigens (Fig . 5), soluble anti-CD 16 antibody,
or E (not shown) did not induce significant accumulation of any of the mRNA
tested . Sepharose-linked anti-CD3 antibodies did not induce mRNA accumula-462
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FIGURE 6 .
￿
Kinetics of accumulation of IFN--y, TNF, and IL-2-R mRNA in human NK cells
stimulated with FcR(CD16) ligands. Total cytoplasmic RNA was extracted from NK cells,
prepared as in Fig . 5, immediately after separation (0 h) or incubated for 1, 2, 4, 8, and I I h
in medium (a), in the presence of rIL-2 (100 U/ml) (b), EA7S (c), or EA7S and rIL-2 (d) .
RNA was electrophoresed (20 jug per lane), transferred to nitrocellulose, and hybridized to
the indicated cDNA probes .
tion for IL-2-R or for the two cytokines in NK cells but, unlike CD16 ligands,
induced it in T cells purified from the same cultures (not shown) .
IFN-7 and TNFmRNA accumulation in NK cells (Fig . 6) occurred within 0.5
h of stimulation (not shown), reached maximal levels at 1 h, and declined after
2 h of stimulation . Accumulation ofIL-2RmRNA (Fig . 6) was detectable at 2 h,
maximal at 4 h, and undetectable or, in four of eight experiments, detectable at
low levels at 11 h ofincubation . The kinetics ofinduction ofmRNA accumulation
was unchanged using FcR(CD16) ligands and rIL-2 in combination . Hybridiza-
tion of the same filters with the 0-actin probe indicated that ,Q-actin mRNA was
detectable at high levels in the same cells, but it did not change significantly at
any time after stimulation (not shown) .
Induction of mRNA Accumulation by CD16 Ligands Does Not Require Protein
Synthesis . NK cells purified from the 10-d cultures were stimulated with EA7S
in the presence of cycloheximide after I h of pretreatment with the inhibitor .
As shown in Fig . 7, both accumulation of IFN-7 mRNA and the higher degree
of accumulation observed upon combined stimulation with CD 16 ligands and
rIL-2 were evident also under these conditions . Such effects were still present at
3 h of culture (not shown) and were also observed for TNFand IL-2R mRNA
(not shown) . Cycloheximide treatment resulted in superinduction of IFN-7 (Fig.
7) and TNF mRNA (not shown) .
Stimulation ofNK Cells with FcR(CD16) Ligands and rIL-2 Induces Transcription
of IL-2-R and Lymphokine Genes .
￿
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FIGURE 7 . Accumulation
￿
of
IFN--y mRNA in human NK cells
stimulated with FcR ligands is in-
dependent of protein synthesis.
NK cells (prepared as described
in Fig . 5) were preincubated (1 h,
37'Q in the absence or presence
of cycloheximide (10 jug/ml) . Me-
dium (dots in 1 and 5), rIL-2 (100
U/ml, dots in 2 and 6), EA7S
(dots in 3 and 7), or EA7S and
rIL-2 (dots in 4 and 8) were then
addedand incubation was contin-
ued for 2.5 h, when cells were
collected and total cytoplasmic RNA was isolated . The indicated amounts ofRNA were hybridized
to the IFN--y cDNA probe pSWIF . Hybridization of the same filter with the cDNA probe pBE (for
28SrRNA) after elution of the IFN--y cDNA probeandethidium bromide staining of a 1% agarose-
formaldehyde gel of the same RNA confirmed that each dot contained equivalent amounts of RNA
and that this was not degraded (not shown) .
TABLE III
FcR(CD16)Ligands Induce Transcription ofIL-2-R, IFN-y and TNF Genes
inNK Cells
* CD3/CD5- NK cells purified from 10-d cultures of PBMC were incubated (20 min,
37 °C) with the indicated stimuli . Nuclear RNA was extracted and the rate of
transcription of the indicated genes analyzed in run-on experiments as described in
Materials and Methods .
$ Values are nuclear RNA transcripts (arbitrary densitometric units) normalized to the
amount of ribosomal RNA transcription, mean ± SE of four experiments, calculated
as described in Materialsand Methods .
to define whether the accumulation ofRNA transcripts for IL-2-R, IFN-7, and
TNFobserved in NK cells stimulated with the FcR(CD16) ligands in thepresence
or absence ofAL-2 is due to induction of transcription of their genes . Nuclear
RNA was prepared from NK cells purified from the 10-d cultures and stimulated
with the different inducers for 20 min ; the results obtained in four experiments
performed are summarized in Table III . IFN-y and, to a lesser extent, TNF and
IL-2-R genes were constitutively transcribed at low rates by the 10-d cultured
NK cells. Upon stimulation with rIL-2, the relative rate of transcription for IL-
2-R, IFN-y, and TNF genes was increased 5.3-, 1 .6-, and 2.5-fold, respectively.
Stimulation of the cells with Sepharose-linked B73.1 antibody induced a 3.4-,
2.6-, and 17.5-fold increase, respectively (Table III and Fig. 8), and these values
were similar to those obtained when the rate of transcription was measured in
cells stimulated with FcR ligands in the presence of rIL-2 . The rate of transcrip-
tion of the (3-actin mRNA was not significantly affected by either stimulus (Fig .
8) .
Stimulus* IL-2-R IFN--y TNF
None 0.92 ± 0 .23$ 3.70 ± 1 .50 2.25 f 0.85
rIL-2 (100 U/ml) 4.92 ± 1.28 5.85 ± 3.02 5.60 ± 1 .28
Sepharose-B73.1 3.10 f 0.71 9.37 ± 3.40 16.87 ± 4.34
Sepharose-B73 .1 +HL-2 3.77 ± 0.32 10.55 ± 4.06 10.72 ± 2.53464
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Discussion
FIGURE 8 . FcR(CD16) ligands in-
duce transcription of IL-2-R, IFN-7,
and TNF genes. NK cells (obtained
as in Fig . 5) were cultured for 20 min
at 37 °C in medium in the absence
(A) or in the presence of Sepharose-
B73 .1 (B). Nuclear RNA was ex-
tracted and used in nuclear run-on
transcription reactions as described
in Materials and Methods . The la-
beled transcripts from each reaction
were hybridized to excess denatured
cDNA immobilized on nitrocellulose
filter. The cDNA used to hybridize
to "P-labeled nRNA were: 1, TNF;
2, ,ß-actin ; 3, pB,,e for 28S RNA; 4,
pSWIF for IFNy ; 5, IL-2R2 for IL-
2R ; 6, pBR322 ; 7, pSP64 . The his-
tograms are densitometric readings
of the bands in the respective films .
In this study we demonstrate that interaction of FcR(CD16) on human NK
cells with ligands induces transcription of genes encoding surface molecules and
cytokines (IFN-y and TNF) relevant to NK cell biology and functions . Our
results indicate that the FcR-mediated regulation of expression of surface acti-
vation antigens and of cytokine production by NK cells follows pathways in part
distinct but synergistic with those induced by other stimuli (e.g ., IL-2) at the
post-transcriptional or translational level .
To obtain a sufficient number of cells for molecular analysis, in most experi-
ments we used CD16+ NK cells purified by negative selection from short-term
bulk cultures of PBL . These NK cell preparations have markers and functions
of fresh NK cells (24, 25) and are thus unlikely to represent only one NK cell
subset, are >95% pure, and are not contaminated with monocytes, as evaluated
usingmAbs or enzymatic staining . Lymphocyte preparations expanded in culture
for a few days have been widely used in studies of T cell physiology . In the case
of both NK and T cells, these preparations are composed of cells that, after
rapid activation and proliferation in vitro, have reverted to a resting state and
lost almost completely expression of activation antigens (24) . Unlike quiescentANEG6N ET AL.
￿
465
peripheral blood T or NK cells, which require a lag period before they can be
induced to proliferate or to express new markers, these cells respond rapidly to
external stimuli, reentering the cell cycle or synthesizing specific products, and
are therefore convenient to study the mechanisms regulating activation, prolif-
eration, and functions of lymphocytes.
Recent studies showed that rIL-2 induces IL-2-R (37) and IFN-'y (38) mRNA
accumulation in fresh Tac- large granular lymphocytes (LGL) upon 2-d stimu-
lation . Our observations using highly purified homogeneous NK cell preparations
that, unlike LGL, are devoid ofmonocytes and other immature CD3-/CD16- T
cells, are consistent with those reports and provide evidence that rIL-2 acts
directly on NK cells, inducing not only IL-2-R and IFN-7, but also TNF mRNA
transcription and accumulation . The experiments showing mRNA accumulation
in the presence of cycloheximide exclude the possibility that other de novo
synthesized lymphokines or proteins (produced by the NK cells or, in the case of
LGL stimulation, by other contaminating cell types) mediate the effect of rIL-2.
Our observation that rIL-2 induces efficiently both transcription and accumula-
tion of mRNA for these proteins but only minimally induces their expression
and secretion suggests that the latter events are regulated at a translational or
post-translational level by factors not induced by rIL-2 alone in purified NK
cells. Unlike fresh PBL (19), the 10-d cultured NK cells respond to rIL-2 with
minimal IFN-,y production. Induction of IFN-7 production in fresh PBL by rIL-
2 has been shown to depend upon the presence ofaccessory HLA-DR' dendritic
cells (39); a role for these accessory cells, highly enriched in LGL preparations,
in regulating expression of IFN-,y at a post-transcriptional level might explain
these contrasting results using cell preparations ofdifferent purity.
The molecular effects induced in FcR-bearing cells with FcR ligands have not
been previously investigated. Stimulation of purified cultured NK cells with
FcR(CD16) ligands alone, unlike stimulation with rIL-2, consistently induced
expression of Tac(CD25) and of other activation markers within 18 h in the
absence of enhanced expression of other antigens endogenously expressed on
cultured NK cells (e.g., HLA-DR, NKH-1, and CD2) and induced production of
low but significant levels ofIFN-,y and TNF. NK cell activation was specifically
induced by FcR(CD16) ligands because neither anti-HLA class I nor anti-CD3
antibodies nor E were effective. FcR(CD16) ligands induced neither activation
antigens nor lymphokine production by CD16- T cells purified from our bulk
cultures. The ready induction of Tac(CD25) expression, cytokine production,
and IL-2-R, IFN-y, and TNF mRNA accumulation upon interaction with Seph-
arose-linked anti-CD3 antibodies and rIL-2 in our purified T cell preparations
demonstrates the ability ofthese cells to respond to T cell-specific stimuli.
We previously showed that restingNK, but not Tcells, are induced to produce
TNFupontarget cell recognition (23), whereas stimulation ofPBL withmitogens
and phorbol esters results in TNF production and accumulation ofTNF mRNA
mostly in T cells (31). Our present results directly prove that NK cells produce
TNF upon specific stimulation with FcR(CD16) ligands that are unable to
stimulate CD16- T cells. Thus, NK cells respond with TNF production to
activation through FcR, as it occurs upon recognition and killing of antibody-
sensitized target cells, and also to activation through surface molecules other466
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than FcR involved in recognition and killing of NK-sensitive target cells. Inter-
action of NK cells with FcR(CD16) ligands or antibody-coated target cells, and
with NK-sensitive target cells results in similar inactivation/exhaustion of cyto-
toxic activity (9, 40). A complete understanding of the activation pathways
involved in the two types of target cell recognition and cytotoxicity by NK cells
awaits a better characterization of the receptor(s) involved in spontaneous NK
cytotoxicity .
When total unseparated fresh PBL were stimulated with FcR ligands,
Tac(CD25) was induced only on a proportion of NK cells and not on T cells. In
the presence of rIL-2, induction of Tac(CD25) by FcR ligands was enhanced on
NK cells and some expression was also observed on T cells, although the
proportion of CD25+ NK cells was always significantly higher than that ofCD25+
T cells. The T cells induced to express Tac among PBL treated with FcR(CD16)
ligands may be the CD16+/CD3 + T cell subset reported by Lanier et al . (41).
However, we cannot exclude that Tac induction on NK and/or on T cells is
indirectly mediated, at least in part, through release of cytokines, e.g., TNF,
lymphotoxin, or IL-1, acting on T and NK cells and produced by contaminating
monocytes, by NK cells, or by T cells present in the total PBL preparations.
TNF has been reported to synergize with rIL-2 to induce Tac(CD25) expression
on NK cells (42) and on activated T cells (43).
Inductionofactivation antigens andsecretion of lymphokines upon FcR(CD16)
ligand interaction at the NK cell surface occur only under conditions that induce
FcR crosslinking at the cell membrane, i.e., using particulate immune complexes
(EA7S) or Sepharose-linked anti-CD16 antibodies. The observation that treat-
ment of NK cells with soluble anti-CD16 antibodies does not result in any of the
effects studied in this report does not exclude the possibility that signal trans-
duction occurs but at a level insufficient to induce the complete series of
intracellular events leading to cell activation. This possibility is supported by the
finding (10; Perussia, B., and G. Trinchieri, unpublished data) that soluble anti-
CD16 antibodies enhance cytotoxic activity of NK cells and by our preliminary
observation that they induce increase of [Ca21],. Interaction of FcR with mono-
meric anti-CD16 antibodies and its crosslinking by particulate ligands induce
down-modulation (4, 8) and probably internalization (44) of FcR on NK cells,
although with different kinetics. The mechanisms by which different conditions
of FcR(CD16) ligand interaction result in distinct biological responses remain to
be investigated.
In cell types other than NK, binding of ligands to the membrane receptors
induces redistribution ofan intracellular antigen pool to the membrane or release
of preformed cytokines. For example, CD21 is redistributed from intracellular
pools in neutrophils upon binding of phenyl-Met-Leu-Phe (45), and preformed
pharmacologically active mediators are released by basophils upon binding of
antigen to FcER-bound IgE (46). We did not test for the possible role of FcR-
induced redistribution of an intracellular antigenic pool or transduction of
secretagogue stimuli for preformed cytokines in mediating effects observed at
the level of protein expression. However, we clearly showed that FcR ligand-
induced IFN-y and TNF production and Tac(CD25) expression depend, at least
in part, on transduction through CD 16 of intracellular signals inducing accu-ANEG6N ET AL.
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mulation ofmRNA for these proteins. The results ofthe experiments performed
in the presence of cycloheximide indicate that no de novo synthesis is required
for signal transduction. The results of nuclear run-on assays indicate that the
observed increases ofmRNA induced with FcR ligands alone are due, at least in
part, to enhanced transcription.
Both induction of activation antigen expression and cytokine production are
synergistically enhanced when rIL-2 and FcR ligands are used in combination.
IFN-y and TNF mRNA accumulation was synergistically increased using CD16
ligands and rIL-2 together, and, on average, equal to fourfold the sum of those
observed usingeach stimulus alone. This value is in the same order ofmagnitude
observed at the protein level, i.e., ^-5.8-fold increase in IFN-'r and TNF produc-
tion using rIL-2 and FcR ligands compared to either stimulus alone. The
observations that the kinetics of mRNA accumulation of both cytokines are
similar and that mRNA accumulation occurs, with any of the stimuli used, after
inhibition of protein synthesis, argue against the possibility that either or both
cytokines are involved in regulating mRNA accumulation for the other.
Unlike the observations for IFN-y andTNF, Tac(CD25) mRNA accumulation
was always significantly induced by rIL-2 but only minimally by CD16 ligands.
An additive rather than synergistic effect on Tac(CD25) mRNA accumulation
was observed in most experiments using the two stimuli in combination. These
results at mRNA level are difficult to reconcile with the observations that
expression of Tac(CD25) antigen at the NK cell surface is efficiently induced by
CD16 ligands, but not by rIL-2, and that the two stimuli synergize in inducing
Tac(CD25) expression . The kinetics ofaccumulation of IL-2-R mRNA induced
by rIL-2 is slower (maximal at 4 h) than that of IFN-y and TNF mRNA induced
by either or both rIL-2 and FcR ligands. Both IFN-y and TNF have been
reported to synergize with IL-2 in inducing Tac(CD25) expression on NK cells
(42, 47), and we cannot exclude that IFN-y and/or TNF produced by NK cells
upon FcR ligand interaction are involved in expression ofCD25. However, we
could not detect IL-2 mRNA transcription in NK cells stimulated by FcR(CD16)
ligand alone or under any of our experimental conditions (data not shown) . A
role for TNF is unlikely since it does not reproducibly induce TAC(CD25)
expression and/or mRNA accumulation in NK cells, and anti-TNF antibodies
do not abolish Tac(CD25) induction on FcR(CD16) ligand-treated NK cells (our
unpublished data). An indirect role of IFN-y or of other unidentified cytokines
cannot yet be excluded, although the inability of cycloheximide to prevent
Tac(CD25) mRNA accumulation indicates that any cytokines with such a role
should be preformed in the cells.
The synergistic effect of FcR ligands and rIL-2 observed at the protein and
cytoplasmic mRNA level was not observed at the level of transcription . The
persistence of synergism in determining accumulation of mRNA in the presence
ofcycloheximide and the superinduction ofmRNA observed in all experimental
conditions after cycloheximide treatment suggest that both IFN-y and TNF
production are suppressed by inhibitory proteins in resting NK cells, as reported
for IFN-y and TNF regulation in other cell types (48, 49). Greater accumulation
of IFN-y and TNF mRNA occurs in NK cells upon FcR(CD16) ligand binding
than upon rIL-2 stimulation, and mRNA accumulation induced by the combined468
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stimuli is still evident at time points at which accumulation induced by either
stimulus alone is not present (4 h or, in several experiments, 11 h). These data
are consistent with the possibility that part of the effect of the FcR ligand
interaction and the synergistic effect ofrIL-2 and FcRligands in NK cells depend
on regulation of inhibitory proteins and/or on stabilization of the mRNA for
both cytokines.
Although both rIL-2 and FcR(CD16) ligands induced transcription of
Tac(CD25), IFN-y and TNF within 20 min, Tac(CD25) transcription was in-
duced at higher levels by rIL-2 than by the CD16 ligands. The reverse was true
for TNF and IFN-y transcription, which were not induced by rIL-2 in two of
the four experiments performed, but were significantly induced by FcR ligands
in all experiments. This observation, although based on a limited number of
experiments and genes, is consistent with the hypothesis that signals transduced
through NK cell-specific receptors result in transcription of genes specifically
involved in NK cell functions, whereas stimuli transduced by factors, such as IL-
2, that affect several distinct cell types, result in preferential activation of genes
(e.g., IL-2-R) relevant to the overall physiology of the cells. Only combined
stimulation would result in complete cell activation through mechanisms, not
completely elucidated, regulating post-transcriptional events . Similar studies on
other cell types (e.g., FcR-bearing B cells and monocytes) could provide signifi-
cant information about the relationship between the mechanisms through which
lineage-specific receptors or functionally similar receptors on different cell types
activate effectors ofnonadaptive and adaptive immunity.
Summary
We report evidence that FcR(CD16) on human NK cells are signal-transducing
molecules that, upon ligand binding, induce transcription of genes encoding
surface activation molecules [IL-2-R(CD25)] and cytokines (IFN-y and TNF)
relevant to NK cell biology and functions. Homogeneous NK and T cell popu-
lations purified from short-term bulk cultures of PBMC with irradiated B
lymphoblastoidcell lines were cultured inthe presence ofFcR ligands (particulate
immune complexes or immobilized anti-CD16 antibodies) alone or with rIL-2.
Upon 18 h of stimulation, NK cells express Tac, TfR, and 4F2 antigens and
produce IFN-y and TNF; both effects are synergistically enhanced in the
presence of rIL-2, which is itself ineffective. Treatment of NK cells with
FcR(CD16) ligands induces accumulation of mRNA for IFN-y and TNF and, to
a lesser extent, IL-2-R with fast kinetics also in the absence of de novo protein
synthesis. rIL-2 and FcR(CD16) ligands synergize to induce mRNA accumula-
tion. mRNA accumulation and transcription of TNF and IFN-y genes induced
by FcR(CD16) ligands are greater than those induced by rIL-2, and the reverse
is true for IL-2-R . The two stimuli do not synergize at the transcriptional level.
These observations indicate that the mechanisms through which FcR(CD16)
ligands and rIL-2 induce NK cell activation are, in part, distinct. Both operate
at the transcriptional level, although other mechanisms are probably induced by
the FcR ligand stimulus per se or in combination with other lymphokines and
synergize at a post-transcriptional or translational level to enhance NK cell
activation .We thank J. Faust and J. Urffer for assistance at the cytofluorograph, M . Hoffman for
editing, and M. Kaplan for secretarial assistance.
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